Evidence map›Paper›PMID 39179625›Full record

ArticleScientific reports2024

The use of artificial neural networks in studying the progression of glaucoma.

Filip Târcoveanu, Florin Leon, Cătălin Lisa, Silvia Curteanu, Andreea Feraru, Kashif Ali, Nicoleta Anton

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Filip TârcoveanuOphthalmology Department, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa" Iasi, University Street No 16, 700115, Iasi, Romania.
Florin LeonFaculty of Automatic Control and Computer Engineering, "Gheorghe Asachi" Technical University of Iasi, 27 Mangeron Street, 700050, Iasi, Romania.
Cătălin LisaDepartment of Chemical Engineering, Faculty of Chemical Engineering and Environmental Protection "Cristofor Simionescu", "Gheorghe Asachi" Technical University of Iasi, 73 Mangeron Street, 700050, Iasi, Romania.
Silvia CurteanuDepartment of Chemical Engineering, Faculty of Chemical Engineering and Environmental Protection "Cristofor Simionescu", "Gheorghe Asachi" Technical University of Iasi, 73 Mangeron Street, 700050, Iasi, Romania. silvia_curteanu@yahoo.com.
Andreea FeraruFaculty of Economic Science, "Vasile Alecsandri" University of Bacau, Calea Marasesti 156, 600115, Bacau, Romania.
Kashif AliCountess of Chester Hospital, Liverpool Rd, Chester, CH21UL, UK.
Nicoleta AntonOphthalmology Department, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa" Iasi, University Street No 16, 700115, Iasi, Romania. nicolofta@gmail.com.ORCID 0000-0002-4987-5049

Funding

UEFISCDI Romania. PN-III-P4-ID-PCE-2020-0551, no. 91/2021
6 · The paper itself

Abstract

In ophthalmology, artificial intelligence methods show great promise due to their potential to enhance clinical observations with predictive capabilities and support physicians in diagnosing and treating patients. This paper focuses on modelling glaucoma evolution because it requires early diagnosis, individualized treatment, and lifelong monitoring. Glaucoma is a chronic, progressive, irreversible, multifactorial optic neuropathy that primarily affects elderly individuals. It is important to emphasize that the processed data are taken from medical records, unlike other studies in the literature that rely on image acquisition and processing. Although more challenging to handle, this approach has the advantage of including a wide range of parameters in large numbers, which can highlight their potential influence. Artificial neural networks are used to study glaucoma progression, designed through successive trials for near-optimal configurations using the NeuroSolutions and PyTorch frameworks. Furthermore, different problems are formulated to demonstrate the influence of various structural and functional parameters on the study of glaucoma progression. Optimal neural networks were obtained using a program written in Python using the PyTorch deep learning framework. For various tasks, very small errors in training and validation, under 5%, were obtained. It has been demonstrated that very good results can be achieved, making them credible and useful for medical practice.

Indexed as

Disease ProgressionGlaucomaNeural Networks, ComputerDeep LearningHumansArtificial neural networksGlaucomaModelling and optimizationSimulation studies

Identifiers

PMID39179625
PMCPMC11344130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.